Financial Performance - Revenue for the year ended December 31, 2025, reached RMB 1,118,404,000, representing a 23.3% increase from RMB 906,846,000 in 2024[3] - Gross profit for the same period was RMB 151,611,000, up from RMB 141,836,000, indicating a gross margin improvement[3] - Operating profit increased to RMB 76,506,000, compared to RMB 63,929,000 in the previous year, reflecting a growth of 19.5%[3] - Net profit for the year was RMB 56,264,000, a rise from RMB 51,283,000, marking an increase of 9.7%[4] - The company's total comprehensive income attributable to owners was approximately RMB 150,600,000, significantly up from RMB 37,800,000 in the previous year[95] - The company's profit before tax for the year ending December 31, 2025, is RMB 74,568,000, an increase from RMB 58,840,000 in 2024, representing a growth of approximately 26.6%[41] - The company's income tax expense for 2025 was RMB 18,304 thousand, compared to RMB 7,557 thousand in 2024, reflecting an increase of 142.5%[39] - The tax expense calculated at a 15% rate for 2025 is RMB 11,391,000, compared to RMB 8,765,000 in 2024, indicating a year-over-year increase of 30.7%[41] Assets and Liabilities - Total assets as of December 31, 2025, amounted to RMB 1,928,615,000, up from RMB 1,694,817,000 in 2024, showing a growth of 13.8%[5] - Total liabilities decreased slightly to RMB 1,330,643,000 from RMB 1,247,421,000, indicating a reduction of 6.7%[6] - The company's total assets as of December 31, 2025, amount to RMB 902,007,000, compared to RMB 801,048,000 in 2024, showing an increase of approximately 12.6%[50] - The company's total liabilities are expected to be repaid as follows: RMB 463,764,000 within one year and RMB 50,187,000 between one and two years[86] Cash and Financing - The company's cash and bank balances increased to RMB 42,676,000 from RMB 32,087,000, representing a 33.1% increase[5] - The total bank borrowings increased from RMB 637,546,000 in 2024 to RMB 702,698,000 in 2025, with a weighted average effective interest rate of 4.30%[83][85] - The unused bank financing amount as of December 31, 2025, is approximately RMB 828,827,000, compared to RMB 359,138,000 in 2024[84] - The company issued convertible bonds with a principal amount of HKD 93,300,000 (approximately RMB 77,224,000) at an annual interest rate of 5.87%[81] Revenue Streams - Revenue from external customers for 2025 reached RMB 1,118,404 thousand, a 23.3% increase from RMB 906,846 thousand in 2024[28] - Sales of products under contract manufacturing services (CMS) amounted to RMB 609,642 thousand in 2025, up from RMB 575,413 thousand in 2024, reflecting a growth of 5.2%[32] - The wholesale business saw significant growth, with revenue reaching approximately RMB 482,200,000, marking an increase of about 57.7% year-on-year[98] - The company's total sales of products in the US market reached RMB 111,515 thousand in 2025, up from RMB 96,524 thousand in 2024, showing a growth of 15.5%[28] Expenses and Costs - The selling costs for the period were approximately RMB 966,800,000, an increase of about 26.4% compared to the previous year[99] - Selling expenses amounted to approximately RMB 29.3 million, a 37.6% increase from the previous year, mainly due to higher employee salaries and travel expenses[103] - Administrative and other operating expenses were approximately RMB 70.1 million, reflecting a 6.4% increase, driven by higher employee salaries and depreciation[104] - Net financing costs decreased by approximately 89.1% to RMB 600,000, attributed to the replacement of high-interest loans with lower-interest loans[105] Research and Development - Research and development costs for 2025 included employee benefits of RMB 9,062 thousand, an increase from RMB 7,779 thousand in 2024, representing a growth of 16.5%[38] - The group plans to continue investing in the research, development, production, and sales of medicinal and edible aerosol products through its subsidiaries in China[126] - By 2026, the group aims to strengthen its supply chain, control procurement costs, and enhance R&D capabilities to develop high-value products and expand market share[127] Corporate Governance - The company has complied with the corporate governance code, except for the combined roles of the chairman and CEO, which are held by the same individual[129] - The audit committee has held three meetings during the reporting period to review financial performance and internal controls[132] - The remuneration committee held two meetings during the reporting period to review the compensation of individual executive directors and senior management[136] - The nomination committee also conducted two meetings to review the board's structure, size, composition, and diversity during the reporting period[138] Future Outlook - The company plans to continue expanding its product lines in home and automotive care, as well as personal care products, to drive future growth[7] - The company plans to continue expanding its e-commerce sales channels and developing high-value-added products[94] - The group will continue to expand its sales network and platforms to achieve business growth and explore other investment opportunities[126] Legal Matters - The company has been awarded a favorable judgment by the Hong Kong High Court, ordering the seller to pay a total compensation of RMB 2,827,500,000 for breaches of the acquisition agreement[124] - The board is seeking legal advice to pursue claims against the seller and/or the operating company for audited financial statements from previous fiscal years[123] Accounting Policies - The group has adopted the revised Hong Kong Accounting Standard 21 regarding the lack of convertibility, which did not impact the financial statements as the functional currency is convertible[14] - The group has changed its accounting policy for land and buildings from a cost model to a revaluation model, resulting in a revaluation surplus of RMB 80,583,000, net of deferred tax of RMB 23,103,000[15] - The group has not early adopted any new or revised Hong Kong Financial Reporting Standards that have been issued but are not yet effective[17]
中国绿岛科技(02023) - 2025 - 年度业绩